Sarcopenia, hypermetabolism, and aging.

Area of Science:

• Gerontology
• Muscle Physiology
• Aging Research

Background:

• Sarcopenia, characterized by age-related muscle mass and strength loss, is a significant factor in elderly disability.
• Its progression is slow, making it difficult to study in short-term, steady-state conditions.
• Current diagnostic methods lack simplicity, relying on indirect measures like DEXA and strength tests.

Purpose of the Study:

• To review the multifactorial nature of sarcopenia, its consequences, and current therapeutic limitations.
• To highlight the need for better understanding and management strategies for age-related muscle loss.

Main Methods:

• Review of existing literature on sarcopenia's etiology, progression, and impact.
• Analysis of current diagnostic tools and their limitations.
• Evaluation of existing and potential treatment strategies.

Main Results:

• Sarcopenia is multifactorial, influenced by hormonal changes, disuse, life events, and diseases.
• Inflammatory cytokines (IL6, TNF alpha) and cortisol significantly contribute to muscle lysis.
• Consequences include loss of strength, mobility, increased falls, and impaired immune response.
• Resistance exercise is the primary validated treatment, though its efficacy is limited during inflammation.

Conclusions:

• Effective management of sarcopenia requires addressing its multifactorial causes, including inflammation and hormonal changes.
• Early intervention targeting muscle hypermetabolism during inflammatory events is crucial.
• Further research is needed for improved diagnostics, understanding etiology and evolution, and conducting controlled therapeutic studies.